Ovid Therapeutics (OVID)
(Delayed Data from NSDQ)
$1.06 USD
0.00 (0.00%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $1.05 -0.01 (-0.94%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/02/2024
Time: -- |
6/2024 | $-0.22 | 0.00% |
Earnings Summary
For their last quarter, Ovid Therapeutics (OVID) reported earnings of -$0.17 per share, beating the Zacks Consensus Estimate of $-0.23 per share. This reflects a positive earnings surprise of 26.09%. Look out for OVID's next earnings release expected on August 02, 2024. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year decrease of 22.22%.
Earnings History
Price & Consensus
Zacks News for OVID
OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
OVID: What are Zacks experts saying now?
Zacks Private Portfolio Services